{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:13Z","timestamp":1789154413194,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,15]]},"DOI":"10.7759\/cureus.79070","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T06:29:21Z","timestamp":1739687361000},"source":"Crossref","is-referenced-by-count":4,"title":["A Case of Erythema Multiforme Following the Administration of Nemolizumab"],"prefix":"10.7759","author":[{"given":"Yoshihito","family":"Mima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14570","article-title":"European Academy of Dermatology and Venereology European Prurigo Project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira MP","year":"2018","unstructured":"Pereira MP, Steinke S, Zeidler C, et al.. European Academy of Dermatology and Venereology European Prurigo Project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018, 32:1059-65. 10.1111\/jdv.14570","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","article-title":"Prurigo nodularis: review and emerging treatments","volume":"26","author":"Leis M","year":"2021","unstructured":"Leis M, Fleming P, Lynde CW. Prurigo nodularis: review and emerging treatments. Skin Therapy Lett. 2021, 26:5-8.","journal-title":"Skin Therapy Lett"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.182","article-title":"Prurigo nodularis: pathogenesis and management","volume":"83","author":"Williams KA","year":"2020","unstructured":"Williams KA, Huang AH, Belzberg M, Kwatra SG. Prurigo nodularis: pathogenesis and management. J Am Acad Dermatol. 2020, 83:1567-75. 10.1016\/j.jaad.2020.04.182","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10498.x","article-title":"Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis","volume":"165","author":"Fukushi S","year":"2011","unstructured":"Fukushi S, Yamasaki K, Aiba S. Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis. Br J Dermatol. 2011, 165:990-6. 10.1111\/j.1365-2133.2011.10498.x","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2018.02.003","article-title":"Prurigo nodularis and its management","volume":"36","author":"Zeidler C","year":"2018","unstructured":"Zeidler C, Yosipovitch G, St\u00e4nder S. Prurigo nodularis and its management. Dermatol Clin. 2018, 36:189-97. 10.1016\/j.det.2018.02.003","journal-title":"Dermatol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.03.020","article-title":"Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis","volume":"58","author":"Haas S","year":"2010","unstructured":"Haas S, Capellino S, Phan NQ, B\u00f6hm M, Luger TA, Straub RH, St\u00e4nder S. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J Dermatol Sci. 2010, 58:193-7. 10.1016\/j.jdermsci.2010.03.020","journal-title":"J Dermatol Sci"},{"key":"ref7","unstructured":"Nemolizumab. (n.d). https.\/\/ss.pmda.go.jp\/ja_all\/search.x?nccharset=52F35CAB&nccharset=FEF28A70&q=+Nemolizumab&ie=UTF-8&page=1."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra SG","year":"2023","unstructured":"Kwatra SG, Yosipovitch G, Legat FJ, et al.. Phase 3 trial of nemolizumab in patients with prurigo nodularis. N Engl J Med. 2023, 389:1579-89. 10.1056\/NEJMoa2301333","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18377","article-title":"Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances","volume":"36","author":"St\u00e4nder S","year":"2022","unstructured":"St\u00e4nder S, Yosipovitch G, Lacour JP, et al.. Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances. J Eur Acad Dermatol Venereol. 2022, 36:1820-5. 10.1111\/jdv.18377","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17589","article-title":"Nemolizumab-induced exacerbation of atopic dermatitis","volume":"[Online ahead of press]","author":"Kamada H","year":"2024","unstructured":"Kamada H, Arakawa N, Kato M, Tanji T, Watabe D, Yanagawa N, Amano H. Nemolizumab-induced exacerbation of atopic dermatitis. J Dermatol. 2024, [Online ahead of press]:10.1111\/1346-8138.17589","journal-title":"J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2023.4566","article-title":"Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis","volume":"33","author":"Kamada H","year":"2023","unstructured":"Kamada H, Arakawa N, Fukui R, Tanji T, Watabe D, Sugai T, Amano H. Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis. Eur J Dermatol. 2023, 33:558-9. 10.1684\/ejd.2023.4566","journal-title":"Eur J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17171","article-title":"A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody","volume":"51","author":"Masuyuki R","year":"2024","unstructured":"Masuyuki R, Sato E, Imafuku S. A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody. J Dermatol. 2024, 51:1252-5. 10.1111\/1346-8138.17171","journal-title":"J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17085","article-title":"Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment","volume":"51","author":"Masuda T","year":"2024","unstructured":"Masuda T, Yonekura S, Kataoka K, et al.. Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment. J Dermatol. 2024, 51:e193-5. 10.1111\/1346-8138.17085","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2013.07.001","article-title":"Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment","volume":"57","author":"Samim F","year":"2013","unstructured":"Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013, 57:583-96. 10.1016\/j.cden.2013.07.001","journal-title":"Dent Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2023.12.2.87","article-title":"Occurrence of erythema multiforme following COVID-19 vaccination: a review","volume":"12","author":"Yousefian M","year":"2023","unstructured":"Yousefian M, Khadivi A. Occurrence of erythema multiforme following COVID-19 vaccination: a review. Clin Exp Vaccine Res. 2023, 12:87-96. 10.7774\/cevr.2023.12.2.87","journal-title":"Clin Exp Vaccine Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist","volume":"51","author":"Sokumbi O","year":"2012","unstructured":"Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012, 51:889-902. 10.1111\/j.1365-4632.2011.05348.x","journal-title":"Int J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102909","article-title":"Erythema multiforme","volume":"77","author":"Kechichian E","year":"2024","unstructured":"Kechichian E, Dupin N, Wetter DA, Ortonne N, Agbo-Godeau S, Chosidow O. Erythema multiforme. EClinicalMedicine. 2024, 77:102909. 10.1016\/j.eclinm.2024.102909","journal-title":"EClinicalMedicine"},{"key":"ref18","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd P","year":"2003","unstructured":"Kidd P. Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003, 8:223-46.","journal-title":"Altern Med Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000323299","article-title":"The role of cytokines\/chemokines in the pathogenesis of atopic dermatitis","author":"Yamanaka KI","unstructured":"Yamanaka KI, Mizutani H. The role of cytokines\/chemokines in the pathogenesis of atopic dermatitis. Current Problems in Dermatology. 2011 (ed): S. Karger AG, Basel, Switzerland; 10.1159\/000323299. 80-92. 10.1159\/000323299"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2021.02.003","article-title":"Dupilumab-induced psoriasis and alopecia areata: case report and review of the literature","volume":"148","author":"Beaziz J","year":"2021","unstructured":"Beaziz J, Bouaziz JD, Jachiet M, Fite C, Lons-Danic D. Dupilumab-induced psoriasis and alopecia areata: case report and review of the literature. Ann Dermatol Venereol. 2021, 148:198-201. 10.1016\/j.annder.2021.02.003","journal-title":"Ann Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341627-a-case-of-erythema-multiforme-following-the-administration-of-nemolizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T06:29:25Z","timestamp":1739687365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341627-a-case-of-erythema-multiforme-following-the-administration-of-nemolizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,15]]}}}